Paul J Schmitt's Net Worth

-$40.6 Thousand

Estimate Recalculated Sep 8, 2024 07:23PM EST

Who is Paul J Schmitt?

Paul J Schmitt does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include TETRALOGIC PHARMACEUTICALS Corp, and ENCORIUM GROUP INC.

SEC CIK

Paul J Schmitt's CIK is 0001390406

Past Insider Trading and Trends

2007 was Paul J Schmitt's most active year for acquiring shares with 1 total transactions. Paul J Schmitt's most active month to acquire stocks was the month of December. 2015 saw Paul J Schmitt paying a total of $52,500.00 for 10,000 shares, this is the most they've acquired in one year.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

TETRALOGIC PHARMACEUTICALS Corp No price found

Investor

Paul J Schmitt owns 10,000 units of Common Stock.acquired a total of 10,000 shares in TETRALOGIC PHARMACEUTICALS Corp at a cost of $40,630.00.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+100.00%
10K
$2.34
$23,356.90
20K
Jul 2
Form 4
—
0
—
—
0
Jan 28
Form 4
∞
20K
$4.10
$81,982.00
20K
Nov 10
Form 4
∞
1.51M
$7.00
—
1.51M
Dec 17
Form 3
—
0
—
—
0
No matching records found

ENCORIUM GROUP INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Mar 30
Form 3
—
0
—
—
0
No matching records found